Compare Immunovant Inc. Common Stock (IMVT) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Riot Platforms Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Riot Platforms Inc trades at $17.23 (market cap $6.96B). The key difference: Immunovant Inc. Common Stock and Riot Platforms Inc are close in size by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Riot Platforms Inc for 16 Days on average.
| IMVT | RIOT | |
|---|---|---|
Market Cap | $6.62B | $6.96B |
Volume | 1,131,364 | 16,308,581 |
Sector | Health | Financials |
52-Week High | $44.96 | $28.67 |
52-Week Low | $17.03 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $5.72B | $7.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT trades at $18.54, down 2.06% on the day, with a bearish technical signal despite oscillators showing some buying interest. The company reported significant losses with a net income margin of -196.28% in 2026, though revenue grew to $675 million. Recent news highlights RIOT's strategic pivot to data center services, securing $9.8 billion in contracted lease revenue through 2048 with major tenants including AMD.
Wall Street remains overwhelmingly bullish with 94.74% buy ratings and a $31.64 consensus price target, representing 71% upside. However, persistent negative earnings, high cash burn, and execution risks in the AI infrastructure transition pose substantial challenges for near-term profitability and shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
